Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study
International Journal of Geriatric Psychiatry · 2023-12 · 38 (12)
DOI: 10.1002/gps.6029 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Geriatric Psychiatry, 2023-12. Verfasst von Yuki Okita und 12 weiteren Autor:innen. Beteiligte Einrichtung: Division of Environmental Medicine and Population Sciences, Department of Social Medicine, Graduate School of Medicine, Osaka University, Suita, Japa…. Hauptthemen laut MEDLINE: Cholinergic Antagonists, Dementia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: Japan Agency for Medical Research and Development, Grants-in-Aid for Scientific Research, Fundamental Research A from the Japan Society for the Promotion of Science, JST FOREST Program.
Themen: Gerontologische Pflege, Demenz
Abstract (Originalsprache)
Objectives
Several studies have investigated that anticholinergic drugs cause cognitive impairment. However, the risk of dementia associated with anticholinergics has not been extensively investigated in the super‐aging society of Japan. We conducted this study to assess the association between anticholinergic drugs and the risk of dementia in older adults in Japan.
Methods
This nested case‐control study used data from the Longevity Improvement & Fair Evidence Study, which includes claim data in Japan from 2014 to 2020. We included 66,478 cases of diagnosed dementia and 328,919 matched controls aged ≥65 years, matched by age, sex, municipality, and cohort entry year. Primary exposure was the total cumulative anticholinergic drugs prescribed from cohort entry date to event date or matched index date, which was the total standardized daily doses for each patient, calculated by adding the total dose of different types of anticholinergic drugs in each prescription, divided by the World Health Organization‐defined daily dose values. Odds ratios for dementia associated with cumulative exposure to anticholinergic drugs were calculated using conditional logistic regression adjusted for confounding variables.
Results
The mean (standard deviation) age at index date was 84.3 (6.9), and the percentage of women was 62.1%. From cohort entry date to event date or matched index date, 18.8% of the case patients and 13.7% of the controls were prescribed at least one anticholinergic drug. In the multivariable‐adjusted model, individuals with anticholinergic drugs prescribed had significantly higher odds of being diagnosed with dementia (adjusted odds ratio, 1.50 [95% confidence interval, 1.47–1.54]). Among specific types of anticholinergic drugs, a significant increase in risk was observed with the use of antidepressants, antiparkinsonian drugs, antipsychotics, and bladder antimuscarinics in a fully multivariable‐adjusted model.
Conclusions
Several types of anticholinergic drugs used by older adults in Japan are associated with an increased risk of dementia. These findings suggest that the underlying risks should be considered alongside the benefits of prescribing anticholinergic drugs to this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Environmental Medicine and Population Sciences, Department of Social Medicine, Graduate School of Medicine, Osaka University, Suita, Japan.
- Biomedical Statistics, Department of Integrated Medicine, Graduate School of Medicine, Osaka University, Suita, Japan.
- Department of Health Care Administration and Management, Kyushu University Graduate School of Medical Sciences, Fukuoka, Japan.
- Department of Neurology, Graduate School of Medicine, Osaka University, Suita, Japan.
- Department of Food Science, Faculty of Home Economics, Otsuma Women's University, Chiyoda-ku, Japan.
ORCID-Profile: Tetsuhisa Kitamura, Fumiko Murata
Förderung
- Japan Agency for Medical Research and Development
- Grants-in-Aid for Scientific Research, Fundamental Research A from the Japan Society for the Promotion of Science
- JST FOREST Program
Zitieren
APA
Okita, Y., Kitamura, T., Komukai, S., Zha, L., Komatsu, M., Narii, N., Murata, F., Megumi, M., Gon, Y., Kimura, Y., Kiyohara, K., Sobue, T., & Fukuda, H. (2023). Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study. International Journal of Geriatric Psychiatry, 38(12). https://doi.org/10.1002/gps.6029
Vancouver
Okita Y, Kitamura T, Komukai S, Zha L, Komatsu M, Narii N, et al. Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study. International Journal of Geriatric Psychiatry. 2023;38(12). doi:10.1002/gps.6029
BibTeX
@article{Okita2023,
author = {Okita, Yuki and Kitamura, Tetsuhisa and Komukai, Sho and Zha, Ling and Komatsu, Masayo and Narii, Nobuhiro and Murata, Fumiko and Megumi, Maeda and Gon, Yasufumi and Kimura, Yasuyoshi and Kiyohara, Kosuke and Sobue, Tomotaka and Fukuda, Haruhisa},
title = {Association of anticholinergic drug exposure with the risk of dementia among older adults in Japan: The LIFE Study},
journal = {International Journal of Geriatric Psychiatry},
year = {2023},
volume = {38},
number = {12},
doi = {10.1002/gps.6029}
}
EUVIMED